Kamari Pharma Ltd

Quick facts

Phase 1 pipeline

• IMP Application KM-001
• KM-001 1% cream 12 weeks treatment
• KM-001 1% cream 16 weeks treatment
• KM-001 cream 1% 12 weeks treatment.
• KM-001 cream 1% 16 weeks treatment.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kamari Pharma Ltd portfolio CI brief
• Kamari Pharma Ltd pipeline updates RSS